GGrantIndex
Sort

46,585 grants matching heart failure

STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines

$631,676
Tomas G Neilan · Massachusetts General Hospital · R01 · FY2019 · HL

Functional Impact of Col18a1/Endostatin Variants in PAH

$631,666
Rachel L Damico · Johns Hopkins University · R01 · FY2019 · HL

Kidney-Associated Diseases after Congenital Heart disease surgery In Children

$631,641
Chirag R Parikh · Johns Hopkins University · R01 · FY2025 · DK

Center for Quantitative Electrocardiography and Cardiac Safety

$631,636
Jean-Philippe Y Couderc · University Of Rochester · U24 · FY2011 · HL

Multi-level analysis of iron metabolism and treatment of chronic kidney disease

$631,561
Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · DK

Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis

$631,536
Paul Werner Buehler · University Of Maryland Baltimore · R01 · FY2025 · HL

A functional genomics pipeline for genetic discovery in diabetic kidney disease

$631,482
Joel N Hirschhorn · Broad Institute, Inc. · R01 · FY2023 · DK

3D combinatorial microenvironments for effective cell based therapy

$631,399
Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2011 · HL

Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing

$631,314
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2025 · HL

Senescence Cardiomyopathy

$631,261
Junichi Sadoshima · Rutgers Biomedical And Health Sciences · R01 · FY2025 · HL

Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue

$631,259
Michael John Davis · University Of Missouri-Columbia · R01 · FY2022 · HL

Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration

$631,200
Todd K Rosengart · Baylor College Of Medicine · R01 · FY2021 · HL

Real-world Evidence to Inform Decisions for Hypertension Treatment Escalation

$631,189
Yuan Lu · Yale University · R01 · FY2024 · HL

Multidimensional Heart Imaging With Ultrasound

$631,183
James F. Greenleaf · Mayo Clinic Rochester · R01 · FY2013 · EB

Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension

$631,156
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2023 · HL

Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension

$631,156
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2021 · HL

Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension

$631,156
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2022 · HL

Search for new MODY genes and molecular studies of their function in beta cells

$631,134
Alessandro Doria · Joslin Diabetes Center · R01 · FY2012 · DK

Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis

$631,119
Eric N Olson · Ut Southwestern Medical Center · R01 · FY2014 · HL

CRS Microbiome: Multi-omic Integrative Longitudinal Experimental (CRS-MILE) study

$631,117
Vijay Ramakrishnan · Indiana University Indianapolis · R01 · FY2024 · AI

Targeted fluorescent indicators for endothelial physiology: Ca(II), ROS, NO

$631,091
Marcel P Bruchez · Carnegie-Mellon University · R01 · FY2016 · EB

Advancing Symptom Science and Management in Cystic Fibrosis: Biological, Social, and Clinical Mechanisms

$631,065
Dionysios Kavalieratos · Emory University · R01 · FY2025 · HL

Post-transcriptional regulation of cardiac hypertrophy

$630,949
Federica Accornero · Brown University · R01 · FY2023 · HL

Mcl-1 as an essential regulator of cardiac mitochondrial function

$630,930
Asa B. Gustafsson · University Of California, San Diego · R01 · FY2011 · HL

Identification of a novel modulator of Pulmonary Artery Hypertension

$630,927
Akiko Hata · University Of California, San Francisco · R01 · FY2017 · HL